Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies
Delmonico, F.L.; Knowles, R.W.; Colvin, R.B.; Cavender, D.E.; Kawai, T.; Bedle, M.; Stroka, D.; Preffer, F.I.; Haug, C.; Cosimi, A.B.
Transplantation Proceedings 25(1 Part 1): 784-785
1993
ISSN/ISBN: 0041-1345 PMID: 8438479 Document Number: 419853
Document emailed within 1 workday
Related Documents
Poston, R.S.; Robbins, R.C.; Chan, B.; Simms, P.; Presta, L.; Jardieu, P.; Morris, R.E. 2000: Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients Transplantation 69(10): 2005-2013Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
Hayes, J.M.; Spencer, W.; Valenzuela, R.; Caulfield, M.; Novick, A.C. 1989: Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model Transplantation Proceedings 21(1 Part 1): 1006-1009
Palmer, A.; Bewick, M.; Kennedy, L.; Welsh, K.; Taube, D. 1989: Anti-HLA antibodies following the transplantation of highly sensitised renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 766-767
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Danon, Y.L.; Cytron, S.; Boner, G.; Shohat, B. 1987: Peripheral blood T cell subpopulations and blocking antibodies in renal allograft recipients Harefuah 113(9): 206-209
The, T.H.; Andersen, H.K.; Spencer, E.S.; Klein, G. 1977: Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients Clinical and Experimental Immunology 28(3): 502-505
Lashkevich, V.A. 2011: Antiviral humanized and human monoclonal antibodies Voprosy Virusologii 56(5): 4-8
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Ettenger, R.B.; Opelz, G.; Walker, J.; Terasaki, P.I.; Malekzadeh, M.H.; Pennisi, A.J.; Uittenbogaart, C.H.; Fine, R.N. 1978: Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients Transplantation Proceedings 10(2): 479-481
Fung, J.J.; Todo, S.; Tzakis, A.; Demetris, A.; Jain, A.; Abu-Elmaged, K.; Alessiani, M.; Starzl, T.E. 1991: Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls Transplantation Proceedings 23(1 Part 1): 14-21
Caron, P.C.; Co, M.S.; Bull, M.K.; Avdalovic, N.M.; Queen, C.; Scheinberg, D.A. 1992: Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies Cancer Research 52(24): 6761-6767
Stock, P.G.; Lantz, M.; Light, S.; Vincenti, F. 1996: In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients Transplantation Proceedings 28(2): 915-916
Woodle, E.S.; Xu, D.; Zivin, R.A.; Auger, J.; Charette, J.; O'Laughlin, R.; Peace, D.; Jollife, L.K.; Haverty, T.; Bluestone, J.A.; Thistlethwaite, J.R. 1999: Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection Transplantation 68(5): 608-616
Sturgiss, S.N.; Davison, J.M. 1991: Perinatal outcome in renal allograft recipients: prognostic significance of hypertension and renal function before and during pregnancy Obstetrics and Gynecology 78(4): 573-577
Hakimi, J.; Chizzonite, R.; Luke, D.R.; Familletti, P.C.; Bailon, P.; Kondas, J.A.; Pilson, R.S.; Lin, P.; Weber, D.V.; Spence, C. 1991: Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys Journal of Immunology 147(4): 1352-1359
Chalopin, J.M.; Rifle, G. 1979: Role of cold lymphocytotoxic antibodies (CLA) in human allograft recipients Transplantation Proceedings 11(2): 1271-1273
Agha, I.A.; Rueda, J.; Alvarez, A.; Singer, G.G.; Miller, B.W.; Flavin, K.; Lowell, J.A.; Shenoy, S.; Howard, T.K.; Ramachandran, V.; Irish, W.; Schnitzle, M.A.; Brennan, D.C. 2002: Short course induction immunosuppression with thymoglobulin for renal transplant recipients Transplantation 73(3): 473-475
Rigotti, P.; Flechner, S.M.; Van Buren, C.T.; Payne, W.T.; Kahan, B.D. 1986: Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression International Surgery 71(1): 38-41